Pnc Financial Services Group, Inc. Atea Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,751 shares of AVIR stock, worth $11,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,751
Previous 4,294
12.65%
Holding current value
$11,102
Previous $15,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AVIR
# of Institutions
123Shares Held
49.3MCall Options Held
54KPut Options Held
98K-
Black Rock Inc. New York, NY9.12MShares$27 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.47MShares$22.1 Million19.85% of portfolio
-
Tang Capital Management LLC San Diego, CA4.83MShares$14.3 Million0.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.71MShares$13.9 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.36 Million2.31% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $246M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...